Literature DB >> 12544993

Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection.

Marco Ranucci1, Giuseppe Isgrò, Pier Paolo Giomarelli, Marco Pavesi, Aldo Luzzani, Iolter Cattabriga, Manuela Carli, Paolo Giomi, Antonio Compostella, Antonio Digito, Valerio Mangani, Vito Silvestri, Enzo Mondelli.   

Abstract

OBJECTIVE: To evaluate a new antimicrobial treatment for central venous catheters in comparison with a traditional treatment, by assessing the catheter colonization and catheter-related bloodstream infection rates in two groups of patients.
DESIGN: Multiple-center, prospective randomized study.
SETTING: The medical and surgical departments of ten institutions. PATIENTS: Patients requiring a central venous catheter for medical or surgical pathologies between June 2000 and November 2001.
INTERVENTIONS: Patients in the control group received a conventional benzalkonium-treated double-lumen central venous catheter, while patients in the oligon group received an oligon-treated (polyurethane combined with silver, carbon, and platinum) catheter with the same characteristics. Data collection included demographics, preexisting clinical conditions, main pathology, catheter insertion, and management data. Catheter colonization was defined as the growth of > or = 15 colony-forming units in culture of catheter segments by the roll-plate method, or > or = 1000 colony-forming units for the sonication method, and catheter-related bloodstream infection was defined as isolation of the same organism from the colonized catheter and from the peripheral blood of a patient with clinical signs of bloodstream infection.
MEASUREMENTS AND MAIN RESULTS: Data were obtained from 545 catheters. Of these, 132 catheters (24.2%) were positive for colonization. Patients in the oligon group demonstrated a lower risk for catheter colonization in the overall population (relative risk, 0.63; 95% confidence interval, 0.46-0.86; p = .003) and in the surgical subgroup (relative risk, 0.5; 95% confidence interval, 0.33-0.76;p = .001). Significant differences between groups were detected for coagulase-negative staphylococci and Gram-negative bacilli colonization rates. Twenty-one patients (3.8%) were positive for catheter-related bloodstream infection, without significant differences between control and oligon groups.
CONCLUSIONS: Oligon treatment is effective in limiting the catheter colonization rate. Due to the limited amount of events, this study lacked the power to detect significant differences in terms of catheter-related bloodstream infection rate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12544993     DOI: 10.1097/00003246-200301000-00008

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  14 in total

Review 1.  Infections associated with medical devices: pathogenesis, management and prophylaxis.

Authors:  Christof von Eiff; Bernd Jansen; Wolfgang Kohnen; Karsten Becker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Anti-infective-treated central venous catheters: a systematic review of randomized controlled trials.

Authors:  B S Niël-Weise; T Stijnen; P J van den Broek
Journal:  Intensive Care Med       Date:  2007-10-17       Impact factor: 17.440

3.  Guidelines for the prevention of intravascular catheter-related infections.

Authors:  Naomi P O'Grady; Mary Alexander; Lillian A Burns; E Patchen Dellinger; Jeffrey Garland; Stephen O Heard; Pamela A Lipsett; Henry Masur; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne G Randolph; Mark E Rupp; Sanjay Saint
Journal:  Clin Infect Dis       Date:  2011-04-01       Impact factor: 9.079

4.  Antimicrobial impregnated catheters in the prevention of catheter-related bloodstream infection in hospitalized patients.

Authors:  Sarah K Wassil; Catherine M Crill; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2007-04

Review 5.  [Infections and sepsis from intravascular catheters].

Authors:  A F Widmer
Journal:  Internist (Berl)       Date:  2005-06       Impact factor: 0.743

6.  Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters.

Authors:  Hend Hanna; Paul Bahna; Ruth Reitzel; Tanya Dvorak; Gassan Chaiban; Ray Hachem; Issam Raad
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

7.  Guidelines for the prevention of intravascular catheter-related infections: recommendations relevant to interventional radiology for venous catheter placement and maintenance.

Authors:  Donald L Miller; Naomi P O'Grady
Journal:  J Vasc Interv Radiol       Date:  2012-08       Impact factor: 3.464

8.  Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial.

Authors:  Cristóbal León; Sergio Ruiz-Santana; Jordi Rello; Maria V de la Torre; Jordi Vallés; Francisco Alvarez-Lerma; Rafael Sierra; Pedro Saavedra; Francisco Alvarez-Salgado
Journal:  Intensive Care Med       Date:  2004-07-20       Impact factor: 17.440

9.  Do antibiotics administered at the time of central venous catheter removal interfere with the evaluation of colonization?

Authors:  Bertrand Souweine; Anne Elisabeth Heng; Claire Aumeran; Fabrice Thiollière; Nicole Gazuy; Patrice Deteix; Ousmane Traoré
Journal:  Intensive Care Med       Date:  2007-09-20       Impact factor: 17.440

10.  Watchful waiting versus immediate catheter removal in ICU patients with suspected catheter-related infection: a randomized trial.

Authors:  Bart J Rijnders; Willy E Peetermans; Charles Verwaest; Alexander Wilmer; Eric Van Wijngaerden
Journal:  Intensive Care Med       Date:  2004-03-04       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.